FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$10.90
+0.26 (+2.44%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+173.4% upside
Low Target
$21.84
Average Target
$29.80
High Target
$37.23
Current Price
$10.90
Current
$10.90
$10.90
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Scenario Analysis
Bear Case
$21.84
100.4%
Low target
Base Case
$29.80
+173.4%
Avg target
Bull Case
$37.23
+241.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$13.25
-17.7% from high
52-Week Low
$5.65
+92.9% from low
Target vs 52W High
$29.80
+124.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |